To further elucidate the molecular mechanisms of anti‐TIF‐1γ autoantibody and association to cancer in adult DM patients‐since an association with cancer was described in the literature, we focused on specifically dysregulated genes in anti‐TIF‐1γ+ patients compared to NDCs or anti‐Mi‐2+ individuals. This evidence concerns the gene TRIM33 and dermatomyositis.